Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Jones

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Psychopharmacology|December 7, 2007
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activityM L Woolley, D J Pemberton, S Bate, et al.
The European Journal of Neuroscience|September 27, 2003
Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonismLaura Wiseman Harris, Trevor Sharp, Jane Gartlon, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1995
Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'.5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMPM J Ellis, A C Lindon, K J Flint, et al.
European Journal of Pharmacology|June 11, 2004
Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainJane E Gartlon, Tracey Ashmeade, Mark Duxon, et al.
Neuroscience|June 6, 2006
Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startleK M Day-Wilson, D N C Jones, E Southam, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene productsK P Haley, J Overhauser, L E Babiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytesJ D Richter, P Young, N C Jones, et al.
Nanoscale|April 4, 2015
Mechanical properties of amyloid-like fibrils defined by secondary structuresC Bortolini, N C Jones, S V Hoffmann, et al.
Schizophrenia Research|June 15, 2007
Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampusMichael K Harte, Marie Cahir, Gavin P Reynolds, et al.
Psychopharmacology|December 8, 2005
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical dataClaire Rourke, Kathryn R Starr, Charlie Reavill, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Psychopharmacology|December 7, 2007
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activityM L Woolley, D J Pemberton, S Bate, et al.
The European Journal of Neuroscience|September 27, 2003
Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonismLaura Wiseman Harris, Trevor Sharp, Jane Gartlon, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1995
Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'.5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMPM J Ellis, A C Lindon, K J Flint, et al.
European Journal of Pharmacology|June 11, 2004
Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainJane E Gartlon, Tracey Ashmeade, Mark Duxon, et al.
Neuroscience|June 6, 2006
Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startleK M Day-Wilson, D N C Jones, E Southam, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene productsK P Haley, J Overhauser, L E Babiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytesJ D Richter, P Young, N C Jones, et al.
Nanoscale|April 4, 2015
Mechanical properties of amyloid-like fibrils defined by secondary structuresC Bortolini, N C Jones, S V Hoffmann, et al.
Schizophrenia Research|June 15, 2007
Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampusMichael K Harte, Marie Cahir, Gavin P Reynolds, et al.
Psychopharmacology|December 8, 2005
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical dataClaire Rourke, Kathryn R Starr, Charlie Reavill, et al.
Pageof 13